|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02552 HUA MEDICINE-B
Nominal 
1.320 +0.020 (+1.538%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 889,367 | (230,114) | (272,981) | (20,906) |
| Net Cash from / (used in) Investing Activities | -- | 8,077 | (4,752) | (68,219) | (14,086) |
| Net Cash from / (used in) Financing Activities | -- | 69,068 | 21,476 | (6,134) | (7,262) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 966,512 | (213,390) | (347,334) | (42,254) |
| Cash & Cash Equivalents at beginning of period | -- | 490,632 | 675,238 | 1,032,090 | 1,105,600 |
| Effect of Foreign Exchange Rate Changes | -- | 3,680 | 28,784 | (9,518) | (31,256) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,460,824 | 490,632 | 675,238 | 1,032,090 |
| Remarks: | Real time quote last updated: 26/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -142,241,000 |
| %Change | 57.877% |
| EPS / (LPS) | RMB -0.150 |
| NBV Per Share (¥) | RMB -0.031 |